When inhibiting G6PDH in renal tumor cells, decreased nicotinamide adenine dinucleotide phosphate (NADPH) level and increased level of ROS were observed, implying critical modulator of PPP in ccRCC redox homeostasis. Here, H6PD is linked to nonpapillary renal cell carcinoma.